Dotimas, Kent John S.

HRN: 12-94-87  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/14/2022
09/21/2022
IV
350 Mg
Q 8 HRS
Acute Suppurative Appendicitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: